| Revenue growth | FY26 turnover at INR 2,140 Cr. |
|---|---|
| Margins | EBITDA margin improved from 6.8% to 10.6% over three years. |
| Demand visibility | Strong; driven by rising demand for nutritious food. |
| Management confidence | High; emphasis on transformation to integrated solution provider. |
Growth
B2C share of premium products rose from 51% (FY23) to 58% (FY26). Gross margin improved 840 bps to 31.5%.
Outlook
FY27 product launches planned including Granuvia and Spinoace. Company targets sustainable value through manufacturing prowess and expanded R&D.
Risks
Challenges include lesser arable land and need for smart farming practices to maintain efficiency.
Last quarter's promises, checked
Delivered
- Guided 25+ products over 3 years → delivered 25+ products (= BEAT)
- Guided Maharatna/Focused share 60-63% → delivered 60-63% (= BEAT)
- Guided FY26 Revenue Growth → delivered 7% YoY growth (= BEAT)
Partly delivered
- Guided 10% export share → delivered 5% (= PARTIAL)
- Guided 120-day WC cycle → delivered 140-150 days (= PARTIAL)
Missed
- Guided PAT growth → delivered slight decline from INR 142Cr to INR 139Cr (= MISS)
Investor Presentation filed with NSE, NSE: INSECTICID. Summary written with AI assistance from the document.
Insecticides (India) Ltd: key numbers
- Share price
- ₹579.85
- Market cap
- ₹1,687 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 13.5×Sector 37.2×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Annual General Meeting
Insecticides (India) Ltd conducted its 29th Annual General Meeting on August 12, 2026. Shareholders deliberated on seven agenda items, with voting results to be disclosed later.
Insecticides (India) Earnings Call Transcript: Key Takeaways
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
- Call
- Guides 100% growth
Insecticides (India) Results Update
Insecticides (India) Limited reported Q1 FY27 revenue of ₹612 crore, a 12% YoY decline. Profit after tax stood at ₹44 crore amid rainfall deficits across India.
- Value
- ₹612.0 Cr
Insecticides (India) Q1 FY27 Results: Net Profit ₹43.9 Cr, Down 24.4% YoY
Insecticides (India) Ltd reported revenue from operations of ₹611.5 Cr (-11.5% YoY) and net profit of ₹43.9 Cr (-24.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹43.9 Cr · -24.4% YoY
Insecticides (India) Board Meeting Date
Insecticides (India) Ltd scheduled a board meeting for August 11, 2026. The meeting will consider unaudited financial results for the quarter ended June 30, 2026.